MDMA rejected as PTSD treatment

A proposal to use the mind-altering drug MDMA as treatment for post-traumatic stress disorder was roundly criticized yesterday. Advisers to the Food and Drug Administration voted 10-1 against claimed benefits of MDMA for PTSD, citing flawed study data, questionable research conduct and significant drug risks, such as heart problems, injury and abuse.